drugset / Trial / NCT04771923

Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding

NCT04771923 ↗

Completed 130 enrolled Clinical Hospital Centre Zagreb
RandomizedCrossoverDouble-blindTreatment

Summary

Endobronchial bleeding is a relatively common complication of diagnostic bronchoscopy. Both tranexamic acid and adrenaline are used topically for the control of endobronchial bleeding. The aim of this study is to compare the efficacy of tranexamic acid with adrenaline in controlling iatrogenic endobronchial bleeding after diagnostic bronchoscopy.

Timeline

Start
2021-02-22
Primary completion
2022-02-04
Completion
2022-02-04

Outcome

Missed primary endpoint

paper Bleeding was stopped in 83.1% of patients (54/65) in both groups (P = 1). PMID 36273651 ↗

paper We found no significant difference between adrenaline and TXA for controlling noncatastrophic iatrogenic endobronchial bleeding PMID 36273651 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.2 mg Other
Subject Tranexamic Acid Small molecule 100 mg Other

Indications